Loading
Alongside how many months a treatment adds, patients should be told how many days it takes from them in clinics, infusions, scans and recovery.
Time toxicity (days with in-person healthcare contact) has been proposed as a formal endpoint and, when reanalysed from trials of drugs offering weeks of benefit, can consume much of the survival gain. The proposal is that trials report days at home versus days in contact with healthcare for each arm, that regulators and guideline bodies display it, and that decision aids present it alongside survival and side-effects.
Shares Patients lack understanding, navigation and agency, Progression-free survival (PFS), Overall survival (OS), Toxicity and quality of life are undervalued.
Shares Progression-free survival (PFS), Overall survival (OS), Toxicity and quality of life are undervalued.
Shares Patients lack understanding, navigation and agency, Toxicity and quality of life are undervalued.
Shares Progression-free survival (PFS), Overall survival (OS).
Shares Patients lack understanding, navigation and agency, Toxicity and quality of life are undervalued.
Shares Progression-free survival (PFS), Overall survival (OS).
Shares Progression-free survival (PFS), Overall survival (OS).
Shares Patients lack understanding, navigation and agency, Toxicity and quality of life are undervalued.